2013
DOI: 10.1007/s00520-013-1838-z
|View full text |Cite
|
Sign up to set email alerts
|

Palliative and oncologic co-management: symptom management for outpatients with cancer

Abstract: Palliative care was associated with significant improvement in nearly all the symptoms evaluated. A sustained change in symptoms was observed in the subset of patients seen for a second follow-up visit. Members of all subgroups improved.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
29
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 20 publications
1
29
0
Order By: Relevance
“…Another study showed a ‡ 1 point pain score improvement in 58% of patients referred to a palliative care clinic. 16 To our knowledge, there are no other studies evaluating the response of AC, NED, and NLLI groups to pain management by the same outpatient palliative care team. Our results suggest that symptomatic patients with a life-limiting illness will benefit the most from interdisciplinary outpatient palliative care.…”
Section: Discussionmentioning
confidence: 97%
“…Another study showed a ‡ 1 point pain score improvement in 58% of patients referred to a palliative care clinic. 16 To our knowledge, there are no other studies evaluating the response of AC, NED, and NLLI groups to pain management by the same outpatient palliative care team. Our results suggest that symptomatic patients with a life-limiting illness will benefit the most from interdisciplinary outpatient palliative care.…”
Section: Discussionmentioning
confidence: 97%
“…Symptoms such as pain, fatigue, depression, and anxiety improved significantly after the initial outpatient palliative care visit to the second follow-up visit (81 days later) and the results were sustained for 120 days. 23 …”
Section: Additional Selected Researchmentioning
confidence: 97%
“…A growing body of research demonstrates benefits in clinical outcomes, patient satisfaction, health care utilization, and cost for palliative care for patients with serious illness, including urologic cancers, regardless of prognosis [3][4][5][6][7][8]. In response to this persuasive research, the American Society for Clinical Oncology has called for palliative care consultation for all patients with cancer with metastatic disease or high symptom burden or both [2], and palliative care is recognized as integral to routine oncology care by the National Comprehensive Cancer Network and the Commission on Cancer.…”
Section: Introductionmentioning
confidence: 99%